Thus, this finding raises the possibility that SULT1A3 might represent a potential target that links oxidative stress (e.g., ROS) and DNA damage together in MLL-r AML cells co-treated with MI-3 and HDAC inhibitors. The gene discussed is HDAC9; the disease is acute myeloid leukemia.